tiprankstipranks
Trending News
More News >
Tubacex SA (ES:TUB)
BME:TUB

Tubacex (TUB) AI Stock Analysis

Compare
16 Followers

Top Page

ES:TUB

Tubacex

(BME:TUB)

Select Model
Select Model
Select Model
Neutral 41 (OpenAI - 5.2)
Rating:41Neutral
Price Target:
€3.00
▼(-3.85% Downside)
Action:ReiteratedDate:03/06/26
The score is held down primarily by deteriorating financial performance and cash burn (negative operating and free cash flow in the last two years) alongside elevated leverage. Technical indicators also point to a bearish trend (below key moving averages with negative MACD). A high dividend yield provides some offset, but the negative P/E reflects loss-making fundamentals.
Positive Factors
Long-term contracts revenue model
A revenue model driven by long-term contracts and project sales provides predictable topline visibility and backlog conversion over quarters. This durability supports planning, aids capital allocation, and cushions near-term volatility in cyclical end markets, improving stability over 2–6 months.
Diversified end-market exposure
Exposure across oil & gas, aerospace, renewables, nuclear and chemicals spreads demand risk and links growth to structural trends like energy transition and infrastructure spending. Diversification reduces reliance on any single cycle and supports steadier revenue streams over coming months.
History of solid operating margins (2022–2024)
Prior multi-year margin strength and scale demonstrate underlying operational capability and pricing power in high-spec steel tubing. That track record suggests the business can restore profitability as volumes or pricing recover, making margins a credible medium-term recovery lever.
Negative Factors
Negative operating and free cash flow
Sustained cash burn erodes liquidity and forces reliance on external funding or asset sales. Negative OCF and FCF in consecutive years heighten refinancing and covenant risk, constrain capex for growth or modernization, and reduce margin for error during cyclical downturns.
Elevated leverage and weakening equity base
High leverage and a shrinking equity base increase financial fragility in a cyclical steel business. Elevated debt amplifies interest and refinancing exposure, limits strategic flexibility, and raises the chance of covenant breaches should industry conditions worsen over the next several quarters.
Recent swing to net loss and revenue contraction
A return to net losses and falling revenue signals weaker demand and margin pressure that can persist multiple quarters. This undermines cash generation, strains stakeholder confidence, and increases the time needed to revert to prior profitable operating levels even if market conditions improve.

Tubacex (TUB) vs. iShares MSCI Spain ETF (EWP)

Tubacex Business Overview & Revenue Model

Company DescriptionTubacex, S.A., together with its subsidiaries, engages in the manufacturing and sale of stainless steel and nickel tubes in Spain and internationally. The company provides seamless stainless steel tubes, including CRA OCTG tubing and casing; aerospace, space exploration, and defense tubing; hydraulic and instrumentation tubing; subsea umbilicals; and medium and high pressure tubes. It also offers round bars, billets, and ingots; fittings, and special and machined components, such as butt welding fittings, tube bends, elbows, tees, reducers and caps; and Tubacoat, a ceramic coating for long steel and high-nickel alloy products. In addition, it provides design and simulation, logistics, repair and maintenance, and added-value services comprising shotpeening, connection threading, bending, cutting, machining and bevelling, welding, overlay, preassemblies, marking, finning, studding, polishing, grooving, lab testing, packaging, and storage services. Its products have applications in low carbon, power generation, oil and gas exploration and production, fertilizer, aerospace, hydrocarbon processing, and other industries. Tubacex, S.A. was incorporated in 1963 and is headquartered in Llodio, Spain.
How the Company Makes MoneyTubacex generates revenue primarily through the sale of its high-quality tubes and pipes, which are essential for various applications in the energy and industrial sectors. The company's revenue model is based on long-term contracts and project-based sales, which provide stability and predictability in earnings. Key revenue streams include the supply of seamless and welded tubes for oil and gas exploration and production, as well as components for aerospace and other industrial applications. Additionally, Tubacex benefits from strategic partnerships with major players in the energy sector, which enhances its market position and contributes to its earnings. The company's focus on innovation and the development of new products for emerging markets, such as renewable energy, also plays a crucial role in driving future revenue growth.

Tubacex Financial Statement Overview

Summary
Weak financial profile: profitability deteriorated into a net loss in 2025 with compressed margins, leverage remains elevated for a cyclical steel business, and cash flow is the key risk with negative operating cash flow in 2024–2025 and mostly negative free cash flow outside 2022–2023.
Income Statement
44
Neutral
Revenue has been volatile: strong growth in 2022–2023, followed by slight contraction in 2024 and a mid-single-digit decline in 2025. Profitability also weakened meaningfully—after positive net income in 2022–2024, the company swung back to a net loss in 2025 with negative operating profit, and margins compressed sharply versus prior years. Positives include a history of solid operating margins in 2022–2024 and a return to higher scale versus 2020–2021, but the latest year’s deterioration reduces confidence in earnings stability.
Balance Sheet
46
Neutral
Leverage is elevated, with debt consistently high and debt-to-equity generally above 1x and often near/above 2x historically. Equity declined in 2025 versus 2024, and returns on equity turned negative in 2025 after being positive in 2022–2024, signaling pressure on the capital base. Offsetting factors include sizeable asset backing and some improvement in leverage from peak levels earlier in the period, but overall balance-sheet risk remains meaningful for a cyclical steel business.
Cash Flow
28
Negative
Cash generation is the weakest area: operating cash flow is negative in 2024 and 2025, and free cash flow is negative across most years except 2022–2023. The move from positive operating cash flow in 2022–2023 to negative in 2024–2025 suggests worsening working-capital and/or lower cash profitability, and free cash outflows increased again in 2025. While free cash flow exceeded net income in some loss years (driven by accounting losses), the consistent cash burn in the last two years raises funding and liquidity risk.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue719.26M767.54M852.39M714.71M341.86M
Gross Profit172.38M466.20M487.83M440.62M194.67M
EBITDA39.89M111.00M127.23M97.33M16.67M
Net Income-31.28M22.85M36.33M20.23M-32.21M
Balance Sheet
Total Assets1.22B1.33B1.21B1.16B1.04B
Cash, Cash Equivalents and Short-Term Investments156.75M236.39M179.01M176.85M157.99M
Total Debt525.08M517.37M507.13M501.23M526.33M
Total Liabilities822.94M850.56M917.82M883.69M792.60M
Stockholders Equity292.31M378.03M240.04M221.48M197.41M
Cash Flow
Free Cash Flow-64.63M-121.94M28.22M60.82M-50.66M
Operating Cash Flow-12.05M-34.98M91.15M87.61M-23.93M
Investing Cash Flow-54.27M-85.63M-60.98M-22.43M-6.64M
Financing Cash Flow-10.33M183.89M-35.12M-38.10M11.05M

Tubacex Technical Analysis

Technical Analysis Sentiment
Negative
Last Price3.12
Price Trends
50DMA
3.40
Negative
100DMA
3.40
Negative
200DMA
3.61
Negative
Market Momentum
MACD
-0.06
Positive
RSI
38.45
Neutral
STOCH
19.48
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ES:TUB, the sentiment is Negative. The current price of 3.12 is below the 20-day moving average (MA) of 3.39, below the 50-day MA of 3.40, and below the 200-day MA of 3.61, indicating a bearish trend. The MACD of -0.06 indicates Positive momentum. The RSI at 38.45 is Neutral, neither overbought nor oversold. The STOCH value of 19.48 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ES:TUB.

Tubacex Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
58
Neutral
€3.01B-78.763.97%4.82%-3.02%43.07%
52
Neutral
€557.81M297.92-6.41%1.39%72.34%
48
Neutral
€362.42M-3.44-92.71%-16.41%-952.46%
41
Neutral
€364.92M-13.1011.13%6.29%-10.37%38.82%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ES:TUB
Tubacex
3.13
-1.09
-25.93%
ES:ACX
Acerinox
12.62
1.31
11.58%
ES:MCM
Miquel y Costas and Miquel
14.20
1.57
12.41%
ES:OHLA
Obrascon Huarte Lain
0.40
-0.10
-19.40%
ES:TLGO
Talgo S.A.
2.78
-0.65
-18.95%
ES:TRG
Tubos Reunidos
0.27
-0.38
-57.94%

Tubacex Corporate Events

Tubacex Shareholders Narrow Syndication Pact to Single Board Appointment
Feb 26, 2026

Spanish shareholders Corporación JM Aristrain and Torre Rioja-Madrid SOCIMI have amended their shareholders’ agreement regarding their stakes in Tubacex, S.A. The addendum clarifies that their share syndication is strictly limited to coordinating voting rights to support the appointment of a single proprietary director representing Torre Rioja on Tubacex’s board.

Under the revised terms, the parties agree to align their political rights attached to Torre Rioja’s entire holding and Corporación Aristrain’s 3.18% stake solely to propose, elect, and maintain Ángel Soria Vaquerizo as proprietary director. This narrows the scope of their cooperation to board representation, signaling that the pact is not intended as a broader concerted action over Tubacex’s corporate control or wider governance matters.

The most recent analyst rating on (ES:TUB) stock is a Hold with a EUR3.50 price target. To see the full list of analyst forecasts on Tubacex stock, see the ES:TUB Stock Forecast page.

Tubacex Updates Board Regulations to Align with Good Governance Code
Feb 25, 2026

Tubacex has formalized a set of Board of Directors Regulations that define how the board and its committees are organized, how they operate, and what standards of conduct apply to directors, the non‑director secretary, and senior managers. The rules are designed to align with applicable laws, the company’s bylaws, and Spain’s Unified Code of Good Governance, with the Board Secretary empowered to resolve interpretative doubts.

The regulations also establish a clear process for amendment, allowing changes to be proposed by the chair, a third of directors, or any committee, and requiring prior reports from the Audit and Compliance Committee and, where relevant, other affected committees. Any modification must be circulated at least ten days before the meeting and approved by a two‑thirds majority of the full board for each substantially independent matter, reinforcing rigor and transparency in corporate governance changes.

The most recent analyst rating on (ES:TUB) stock is a Hold with a EUR3.50 price target. To see the full list of analyst forecasts on Tubacex stock, see the ES:TUB Stock Forecast page.

Tubacex Sets Date for Release of 2025 Annual Results and Investor Webcast
Feb 5, 2026

Tubacex has announced that it will release its 2025 annual results on February 27, 2026, before the opening of financial markets, and will present the figures to investors and analysts via a webcast later that morning. The scheduled disclosure underlines the company’s adherence to market transparency requirements and provides a clear timetable for shareholders and other stakeholders to assess its performance and outlook for the past financial year.

The most recent analyst rating on (ES:TUB) stock is a Hold with a EUR3.50 price target. To see the full list of analyst forecasts on Tubacex stock, see the ES:TUB Stock Forecast page.

Tubacex Sets Date for Release of 2025 Annual Results
Feb 4, 2026

Tubacex has notified the market that it will publish its 2025 annual results on Friday, 27 February 2026, before the opening of financial markets, and will present the figures to investors and analysts via a webcast later that morning. The scheduled disclosure underlines the company’s adherence to market transparency requirements and provides stakeholders with a clear timetable for assessing Tubacex’s financial and operational performance for 2025.

The most recent analyst rating on (ES:TUB) stock is a Hold with a EUR3.50 price target. To see the full list of analyst forecasts on Tubacex stock, see the ES:TUB Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 06, 2026